
NevaSoft provides clinical laboratories with AI-powered software and devices to enable earlier and more standardized detection of blood cancers and hematological diseases. The company combines artificial intelligence, machine learning, and image processing with laboratory automation and digital data analysis to deliver an AI decision-support system for hematology/oncology results and an automated blood staining device. Its business model includes SaaS for analysis software and device sales for laboratory hardware, with integrations into laboratory workflows and partnerships with diagnostic manufacturers. NevaSoft targets hematology and oncology laboratories and is positioned to scale in the medical diagnostics market.

NevaSoft provides clinical laboratories with AI-powered software and devices to enable earlier and more standardized detection of blood cancers and hematological diseases. The company combines artificial intelligence, machine learning, and image processing with laboratory automation and digital data analysis to deliver an AI decision-support system for hematology/oncology results and an automated blood staining device. Its business model includes SaaS for analysis software and device sales for laboratory hardware, with integrations into laboratory workflows and partnerships with diagnostic manufacturers. NevaSoft targets hematology and oncology laboratories and is positioned to scale in the medical diagnostics market.
Company: NevaSoft — AI software and devices for hematology/oncology diagnostics
Founded: 2021
Business model: SaaS for analysis software + device sales for laboratory hardware
Recent financing: Equity crowdfunding announced Oct 12, 2023
Known investors: Fonbulucu; Maqasid Asset Management
Diagnostics for hematology and oncology laboratories (blood cancer detection and hematological disease identification).
2021
Biotechnology
obfuscated
Crunchbase lists one funding round and two investors
“Fonbulucu; Maqasid Asset Management”